RECENT FUNDING
  1. Recent Funding
  2. Investors
  3. Cormorant Asset Management
C

Cormorant Asset Management portfolio

Cormorant Asset Management has 16 portfolio companies on record at Recent Funding, with 4 investments in the last 12 months.

Type: Investor.
Portfolio on Recent Funding: 16.
Deals, last 12 months: 4.
Rounds led: 3 of 15.
Capital in their rounds: $2.05B.
Latest deal: Dren Bio · Oct 29, 2026.
About this page

It led 3 of the 15 rounds it joined. Its most recent investment on record is Dren Bio's $350M funding round in October 2026, alongside Taiho Ventures, General Catalyst, HBM Healthcare Investments and 6 others. By category, its portfolio leans toward Health and bio (16) and Education (1). It has co-invested with OrbiMed, SR One and Janus Henderson Investors, most often OrbiMed (5 rounds).

What Cormorant Asset Management invests in

Cormorant Asset Management recent investments

How Cormorant Asset Management invests

StageDealsCapital in rounds
Series B+ 11 73%$1.36B
Series A 3 20%$344M
round 1 7%$350M
YearDealsCapital in rounds
2020 1 7%$86M
2021 2 13%$300M
2022 2 13%$214M
2023 1 7%$75M
2024 2 13%$390M
2025 4 27%$348M
2026 3 20%$640M

Cormorant Asset Management portfolio companies

CompanyRound with Cormorant Asset ManagementTotal raisedLatest raise
DDren Bio
Health and bio
round · $350M$415MOct 29, 2026
round
SStar Therapeutics
Health and bio
Series B+ · $200M$415MOct 23, 2026
Series B+
EEpicrispr Biotechnologies
Health and bio
Series B+ · $90M$158MAug 11, 2026
Series B+
AAspen Neuroscience
Health and bio
Series B+ · $115M$339MNov 20, 2025
Series B+
FFore Biotherapeutics
Health and bio
Series B+ · $40M$182.4MJul 8, 2026
Series B+
UUmoja Biopharma
Health and bio
Series B+ · $100M$363MJan 14, 2025
Series B+
OOrbis Medicines
Health and bio
Series A · $93M$121MJan 6, 2025
Series A
TThird Arc Bio
Health and bio
Series A · $165M · lead$217MFeb 4, 2026
Series A
AAltruBio
Health and bio
Series B+ · $225M$288MMay 21, 2024
Series B+
MMOMA Therapeutics
Health and bio
Series B+ · $150M$236MMay 10, 2022
Series B+
AArkuda Therapeutics
Health and bio
Series B+ · $64M · lead$108MFeb 10, 2022
Series B+
SStrata Oncology
Health and bio
Series B+ · $90M$128MJul 28, 2021
Series B+
NnChroma Bio
Health and bio
backer$75MDec 12, 2024
round
EEnsoma
Health and bio
backer$50MMay 16, 2023
Series B+
VVelosbio
Health and bio
backer$58MAug 2, 2026
Series B+
GGC Therapeutics
Health and bio
backerundisclosedSep 23, 2024
Series A

Most frequent co-investors

Similar investors

Investors whose portfolios on Recent Funding center on the same category (Health and bio).

How this is counted

Share is of the 15 rounds on Recent Funding that name Cormorant Asset Management. Rounds with no announced date are left out of the year split, and "round" is a round whose stage is not on file.

Portfolio companies are the companies on Recent Funding with a round that lists Cormorant Asset Management, which is a subset of its real portfolio. API: /api/v1/investors/cormorant-asset-management (get a free API key). More: the most active VC firms and new venture capital funds.

Top raises, every week

The week's top funded startups and market insights, in your inbox every Monday.

Unsubscribe anytime · privacy